We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+4.73%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$966M
AUM Growth
+$51.6M
(+5.6%)
Cap. Flow
+$37M
Cap. Flow
% of AUM
3.83%
Top 10 Holdings %
Top 10 Hldgs %
72.41%
Holding
47
New
16
Increased
6
Reduced
12
Closed
2
Top Buys
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$57.2M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$26.2M |
| 3 |
AKCA
Akcea Therapeutics Inc
AKCA
|
+$22.8M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$20.7M |
| 5 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
+$13.5M |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$55.8M |
| 2 |
Ascendis Pharma A/S
ASND
|
+$25.9M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
+$20.9M |
| 4 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$17.7M |
| 5 |
Wave Life Sciences
WVE
|
+$16.6M |
Sector Composition
| 1 | Healthcare | 88.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
1
Kyntra Bio
KYNB
$30M
| $123M | 12.68% |
80,690
| – | – |
|
2
Assembly Biosciences
ASMB
$528M
| $109M | 11.31% |
245,264
| – | – |
|
|
3
Ironwood Pharmaceuticals
IRWD
$665M
| $94.9M | 9.82% |
6,139,099
-1,323,488
| -18% | -$20.9M |
|
|
4
Ascendis Pharma A/S
ASND
$17.5B
| $77M | 7.97% |
1,087,257
-376,810
| -26% | -$25.9M |
|
5
Kura Oncology
KURA
$1B
| $68.3M | 7.07% |
3,902,975
-1,700
| -0% | -$32.6K |
|
6
Scholar Rock
SRRK
$6.47B
| $61M | 6.31% |
2,367,378
-303,783
| -11% | -$5.58M |
|
|
DRNA
7
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $58M | 6.01% |
3,802,327
+841,180
| +28% | +$12.2M |
|
|
ONCE
8
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $45.7M | 4.73% |
+837,048
| New | +$57.2M |
|
9
MacroGenics
MGNX
$271M
| $31.8M | 3.29% |
1,481,086
+30,480
| +2% | +$650K |
|
10
Arcus Biosciences
RCUS
$3.52B
| $31.2M | 3.23% |
2,236,387
| – | – |
|
|
KZR
11
DELISTED
Kezar Life Sciences
KZR
| $27.6M | 2.85% |
128,820
+1,600
| +1% | +$279K |
|
|
AKCA
12
DELISTED
Akcea Therapeutics Inc
AKCA
| $26.4M | 2.74% |
+755,120
| New | +$22.8M |
|
|
13
CRISPR Therapeutics
CRSP
$4.97B
| $22.2M | 2.3% |
+500,000
| New | +$26.2M |
|
|
14
Ultragenyx Pharmaceutical
RARE
$3.12B
| $19.4M | 2.01% |
+254,000
| New | +$20.7M |
|
15
Dianthus Therapeutics
DNTH
$5.47B
| $18.5M | 1.91% |
96,131
| – | – |
|
|
UBX
16
DELISTED
Unity Biotechnology
UBX
| $15.8M | 1.63% |
96,711
-71,353
| -42% | -$11.7M |
|
|
SURF
17
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $14.9M | 1.54% |
1,363,479
+472,671
| +53% | +$5.54M |
|
|
RUBY
18
DELISTED
Rubius Therapeutics, Inc
RUBY
| $14.2M | 1.47% |
+592,128
| New | +$13.5M |
|
|
EIGR
19
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $12.5M | 1.29% |
34,650
| – | – |
|
20
Arbutus Biopharma
ABUS
$897M
| $11.6M | 1.2% |
+1,231,800
| New | +$12.2M |
|
21
Spero Therapeutics
SPRO
$97.9M
| $9.38M | 0.97% |
+892,741
| New | +$10.4M |
|
|
IMDZ
22
DELISTED
Immune Design Corp.
IMDZ
| $7.74M | 0.8% |
2,241,900
-2,195,700
| -49% | -$8.24M |
|
23
Zai Lab
ZLAB
$2.3B
| $6.82M | 0.71% |
+350,000
| New | +$7.59M |
|
24
Neurogene
NGNE
$779M
| $6.64M | 0.69% |
113,294
+55,794
| +97% | +$3.29M |
|
25
Elanco Animal Health
ELAN
$12.8B
| $6.63M | 0.69% |
+190,000
| New | +$6.68M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM